Medy-Tox Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 3,631.39 million compared to KRW 2,796.47 million a year ago. Net income was KRW 37,010 million compared to KRW 94,153.92 million a year ago.

Basic earnings per share from continuing operations was KRW 5,491.4286 compared to KRW 14,587.7551 a year ago. Diluted earnings per share from continuing operations was KRW 5,489.5238 compared to KRW 14,517.0068 a year ago. Basic earnings per share was KRW 5,766 compared to KRW 16,083 a year ago.

Diluted earnings per share was KRW 5,764 compared to KRW 16,005 a year ago.